Why Treace Medical Concepts, Inc. (TMCI) stock rose 18.6% on Monday, November 9, 2026

Treace Medical Concepts, Inc. (TMCI) closed at $4.78, up 18.61% on Monday, November 9, 2026, on volume of 1,094,501 shares (4.1× its 3-month average); market value about $300.0M.

What happened: primary sources

Events Nexqual found for TMCI on Monday, November 9, 2026 or the trading day before (November 6, 2026):

• Nov 6, 2026: Reported quarterly results (SEC 8-K) for the quarter ended Sep 30, 2026: EPS −$0.15 vs consensus −$0.25 (beat), on the analysts' basis (usually adjusted, not GAAP). source
• Nov 6, 2026: SEC 10-Q: Quarterly report, period ended Sep 30, 2026 source
• Nov 9, 2026: Stifel: Upgrade, Hold → Buy, price target $4.5 → $6.5

These are listed as context. A filing or rating change on the same day is not proof that it caused the move; read the source.

More on TMCI

TMCI stock page: price, SEC financials, insider trades, superinvestor holders, analyst estimates and options. Other big moves that day: November 9, 2026.

Sources: SEC EDGAR, Nexqual Earnings Flash, analyst rating changes, Nexqual market data. Built November 10, 2026 at 16:24 UTC. Not investment advice.

Data source: Nexqual. Last updated: November 10, 2026 at 16:24 UTC. This page is informational and not investment advice.

For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt